Abstract:Bioinformatics is a rapidly growing field involving the application of computational methods to the analysis and interpretation of biological data. An important task in bioinformatics is the identification of novel drug-target interactions (DTIs), which is also an important part of the drug discovery process. Most computational methods for predicting DTI consider it as a binary classification task to predict whether drug target pairs interact with each other. With the increasing amount of drug-target binding affinity data in recent years, this binary classification task can be transformed into a regression task of drug-target affinity (DTA), which reflects the degree of drug-target binding and can provide more detailed and specific information than DTI, making it an important tool in drug discovery through virtual screening. Effectively predicting how compounds interact with targets can help speed up the drug discovery process. In this study, we propose a deep learning model called TC-DTA for the prediction of the DTA, which makes use of the convolutional neural networks (CNN) and encoder module of the transformer architecture. First, the raw drug SMILES strings and protein amino acid sequences are extracted from the dataset. These are then represented using different encoding methods. We then use CNN and the Transformer's encoder module to extract feature information from drug SMILES strings and protein amino acid sequences, respectively. Finally, the feature information obtained is concatenated and fed into a multi-layer perceptron for prediction of the binding affinity score. We evaluated our model on two benchmark DTA datasets, Davis and KIBA, against methods including KronRLS, SimBoost and DeepDTA. On evaluation metrics such as Mean Squared Error, Concordance Index and r2m index, TC-DTA outperforms these baseline methods. These results demonstrate the effectiveness of the Transformer's encoder and CNN in the extraction of meaningful representations from sequences, thereby improving the accuracy of DTA prediction. The deep learning model for DTA prediction can accelerate drug discovery by identifying drug candidates with high binding affinity to specific targets. Compared to traditional methods, the use of machine learning technology allows for a more effective and efficient drug discovery process.

MetDIT: Transforming and Analyzing Clinical Metabolomics Data with Convolutional Neural Networks

Integrating Machine Learning in Metabolomics: A Path to Enhanced Diagnostics and Data Interpretation

OmicsMapNet: Transforming omics data to take advantage of Deep Convolutional Neural Network for discovery

Deep metabolome: Applications of deep learning in metabolomics

Advances in AI and machine learning for predictive medicine

Applications of machine learning in metabolomics: Disease modeling and classification

An integrated deep learning framework for the interpretation of untargeted metabolomics data

Study Of The Application Of Deep Convolutional Neural Networks (Cnns) In Processing Sensor Data And Biomedical Images

Multiple Compounds Recognition from the Tandem Mass Spectral Data Using Convolutional Neural Network.

Transformer-based deep learning integrates multi-omic data with cancer pathways

TransMed: Transformers Advance Multi-Modal Medical Image Classification

A Comprehensive Evaluation of Metabolomics Data Preprocessing Methods for Deep Learning

DTox: A deep neural network-based in visio lens for large scale toxicogenomics data

TC-DTA: predicting drug-target binding affinity with transformer and convolutional neural networks

Intelligent medical diagnosis and treatment for diabetes with deep convolutional fuzzy neural networks

Multi-Omics Analysis for Improved Diagnosis, Prognosis, and Drug Response Prediction in Digestive System Tumors

EVA: Evaluation of Metabolic Feature Fidelity Using a Deep Learning Model Trained With Over 25000 Extracted Ion Chromatograms.

Deep-DRM: a computational method for identifying disease-related metabolites based on graph deep learning approaches

METnet: A novel deep learning model predicting MET dysregulation in non-small-cell lung cancer on computed tomography images

Multi-modal Deep Learning

Gut metagenome-derived image augmentation and deep learning improve prediction accuracy of metabolic disease classification